• Eur Spine J · Dec 2024

    Temporal validation of the SORG 90-Day and 1-Year machine learning algorithms for survival of patients with spinal metastatic disease.

    • Hester Zijlstra, R H Kuijten, Anirudh V Bhimavarapu, Amanda Lans, Rachel E Cross, Ahmad Alnasser, Aditya V Karhade, Jorrit-Jan Verlaan, Olivier Q Groot, and Joseph H Schwab.
    • Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA. hesterzijlstra@outlook.com.
    • Eur Spine J. 2024 Dec 5.

    PurposeThe SORG-MLA was developed to predict 90-day and 1-year postoperative survival in patients with spinal metastatic disease who underwent surgery between 2000 and 2016. Due to the constant changes in treatment methods, it is essential to perform temporal validation with a recent patient population. Therefore, the purpose of this study was to validate the Skeletal Oncology Research Group machine learning algorithms (SORG-MLA) using a contemporary patient cohort.MethodsThis retrospective cohort study investigated patients who received surgical treatment for spinal metastases between January 2017 and July 2021 in two tertiary care centers in the US. Eighteen input variables needed for the SORG-MLA were collected including primary tumor, Eastern Cooperative Oncology Group (ECOG) Performance Status, and nine preoperative laboratory values. Outcomes were defined as mortality at 90-day and 1-year postoperative. Performance was assessed using calibration, discrimination, overall performance, and decision curve analysis.ResultsIn total, 464 patients were included. The validation cohort varied from the development cohort in multiple variables. Despite these differences, the SORG-MLA continued to perform well on calibration, discrimination (area under the receiver operating characteristic curve [AUC] 0.81 (95% confidence interval [CI], 0.77-0.86) for 90-day, AUC 0.75 (95% CI, 0.71-0.80) for 1-year), Brier score, and decision curve analyses.ConclusionsIn spite of recent progress in treating spinal metastases, SORG-MLA for survival in patients with spinal metastatic disease continued to perform well on temporal validation. However, updating the models using a contemporary patient cohort and stratifying by primary tumor could further improve the performance.© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…